Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
N Engl J Med
.
2017 Mar 2;376(9):891.
doi: 10.1056/NEJMc1615712.
Authors
Thomas C Williams
1
,
Emma Stewart
2
Affiliations
1
Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom thomas.christie.williams@ed.ac.uk.
2
NHS Lothian, Edinburgh, United Kingdom.
PMID:
28249136
DOI:
10.1056/NEJMc1615712
No abstract available
Publication types
Letter
Comment
MeSH terms
Cardiovascular Diseases
Diabetes Mellitus, Type 2*
Glycated Hemoglobin*
Humans
Substances
Glycated Hemoglobin A
Grants and funding
MC_PC_U127597124/MRC_/Medical Research Council/United Kingdom